|
1.
|
|
7 p, 593.4 KB |
Asthma control and COPD symptom burden in patients using fixed-dose combination inhalers (SPRINT study)
/
Roche, Nicolas (Respiratory Medicine, Cochin Hospital, APHP Centre University of Paris, Institut Cochin (UMR1016), Paris, France) ;
Plaza, Vicente (Institut d'Investigació Biomèdica Sant Pau) ;
Backer, Vibeke (Copenhagen University. Department of Respiratory Medicine) ;
van der Palen, Job (Medisch Spectrum Twente. Medical School Twente) ;
Cerveri, Isa (Unit of Respiratory Diseases, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy) ;
Gonzalez, Chelo (Unit of Statistics and Data Management, Experior SL, 46139 La Pobla de Farnals, Valencia, Spain) ;
Safioti, Guilherme (Teva Pharmaceutical Industries Ltd, Amsterdam, The Netherlands) ;
Scheepstra, Irma (Teva Pharmaceutical Industries Ltd, Amsterdam, The Netherlands) ;
Patino, Oliver (Teva Pharmaceutical Industries Ltd, Amsterdam, The Netherlands) ;
Singh, Dave (Centre for Respiratory Medicine and Allergy, University of Manchester, and the Medicines Evaluation Unit, University Hospital of South Manchester NHS Foundation Trust) ;
Universitat Autònoma de Barcelona
Previous studies have found suboptimal control of symptom burden to be widespread among patients with asthma and chronic obstructive pulmonary disease (COPD). The Phase IV SPRINT study was conducted in 10 countries in Europe to assess asthma disease control and COPD symptom burden in patients treated with a fixed-dose combination (FDC) of inhaled corticosteroids (ICS) and long-acting beta agonists (LABAs). [...]
2020 -  10.1038/s41533-019-0159-1
NPJ primary care respiratory medicine, Vol. 30 (january 2020)
|
|
|
2.
|
|
10 p, 345.6 KB |
Prognostic assessment in COPD without lung function : the B-AE-D indices
/
Boeck, Lucas (University Hospital Basel (Basilea, Suïssa)) ;
Soriano, Joan B.. (Instituto de Investigación Hospital Universitario de la Princesa) ;
Brusse-Keizer, Marjolein (Medical School Twente, Medisch Spectrum Twente, Enschede, The Netherlands) ;
Blasi, Francesco (Dept of Pathophysiology and Transplantation, University of Milan, IRCCS Fondazione Ospedale Maggiore Policlinico Cà Granda, Milan, Italy) ;
Kostikas, Konstantinos (University of Thessaly Medical School, Larissa, Greece) ;
Boersma, Wim (Dept of Pneumology, Medisch Centrum, Alkmaar, The Netherlands) ;
Milenkovic, Branislava (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Belgrade, Serbia) ;
Louis, Renaud (Dept of Pneumology, University of Liege, Liege, Belgium) ;
Lacoma, Alicia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Djamin, Remco (Dept of Pneumology, Amphia Hospital, Breda, The Netherlands) ;
Aerts, Joachim (Dept of Pneumology, Amphia Hospital, Breda, The Netherlands) ;
Torres, Antoni (Hospital Clínic i Provincial de Barcelona) ;
Rohde, Gernot (Dept of Respiratory Medicine, Maastricht University Medical Center, Maastricht, The Netherlands) ;
Welte, Tobias (Dept of Pneumology, Medizinische Hochschule, Hannover, Germany) ;
Martinez-Camblor, Pablo (Universidad Autónoma de Chile) ;
Rakic, Janko (University Hospital Basel (Basilea, Suïssa)) ;
Scherr, Andreas (University Hospital Basel (Basilea, Suïssa)) ;
Koller, Michael (University Hospital Basel (Basilea, Suïssa)) ;
van der Palen, Job (Medical School Twente, Medisch Spectrum Twente, Enschede, The Netherlands) ;
Marin, Jose M. (Hospital Universitario Miguel Servet (Saragossa)) ;
Alfageme, Inmaculada (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ;
Almagro, Pere (Mútua Terrassa) ;
Casanova, Ciro (Hospital Universitario Nuestra Señora de Candelaria (Santa Cruz de Tenerife)) ;
Esteban, Cristobal (Hospital de Galdakao (Usansolo, Biscaia)) ;
Soler-Cataluña, Juan J. (Hospital Arnau de Vilanova (Lleida, Catalunya)) ;
De Torres, Juan Pablo (Clínica Universidad de Navarra) ;
Miravitlles, Marc (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Celli, Bartolomé R. (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ;
Tamm, Michael (University Hospital Basel (Basilea, Suïssa)) ;
Stolz, Daiana (University Hospital Basel (Basilea, Suïssa)) ;
Universitat Autònoma de Barcelona
Several composite markers have been proposed for risk assessment in chronic obstructive pulmonary disease (COPD). However, choice of parameters and score complexity restrict clinical applicability. Our aim was to provide and validate a simplified COPD risk index independent of lung function. [...]
2016 - 10.1183/13993003.01485-2015
European respiratory journal, Vol. 47 (april 2016) , p. 1635-1644
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
